Dr Rick Chapman Discusses Key Insights From the Center’s Rare Disease Project

The Orphan Drug Act in the Modern Drug Pricing Era

The Orphan Drug Act revolutionized rare disease treatment, yet rising costs and access issues challenge equitable health care solutions.

Experts Warn That CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Child receiving vaccine | Image credit: Drazen - stock.adobe.com

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

Experts raise concerns that CDC childhood immunization changes could reduce vaccine uptake and weaken trust in public health guidance.

Coalition's Conversation: State of the Obesity Market

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Tom Belmont, AP, CLU, ChFC, RHU, REBC, president and CEO of the Greater Philadelphia Business Coalition on Health (Series host and moderator) Patrick Henry, PharmD, MBA, clinical advisor at Employers Health Emily Malloy, PharmD, pharmacy resident at Employers Health

Precision, Access, and the Patient Journey: Navigating the Complexities of Modern Oncology

Explore the evolving GLP-1 landscape with insights from industry experts, shaping future health strategies and plan designs for employers.

Miami | Image Credit: ©SeanPavonePhoto-stock.adobe.com

Is Rare Disease Policy a Stress Test of US Health Care?

Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast cancer care and payer friction.

Related Content

The Orphan Drug Act in the Modern Drug Pricing Era

The Orphan Drug Act revolutionized rare disease treatment, yet rising costs and access issues challenge equitable health care solutions.

Experts Warn That CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

Experts raise concerns that CDC childhood immunization changes could reduce vaccine uptake and weaken trust in public health guidance.

Coalition's Conversation: State of the Obesity Market

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Precision, Access, and the Patient Journey: Navigating the Complexities of Modern Oncology

Explore the evolving GLP-1 landscape with insights from industry experts, shaping future health strategies and plan designs for employers.